Q4 Systemwide Pro Forma Revenue increased to

$25.0 million

, with full year 2020 Systemwide Pro Forma sales of

$88.1 million

Q4 Adjusted EBITDA increased 59% sequentially to

$5.9 million

, representing Adjusted EBITDA margin of 24%

Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of

$170

-180 million and Adjusted EBITDA of

$40

-50 million

The Company’s existing licensed projects at maturity represent a long-term revenue and EBITDA opportunity upwards of

$650 million

and

$250 million

, respectively

PHOENIX

,

April 6, 2021

/PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (”

4Front

” or the ”

Company

“) today announced its financial results for the fourth quarter and fiscal year ended

December 31, 2020

. All financial information is presented in U.S. dollars unless otherwise indicated.

Fourth Quarter 2020 (“Q4 2020”) Financial Results Highlights

• Systemwide Pro Forma Revenue was
  
  $25.0 million
  
• GAAP-reported revenue was
  
  $17.0 million
  
• Adjusted EBITDA was
  
  $5.9 million
  

Fiscal Year 2020 (“FY 2020”) Financial Results Highlights

• Systemwide Pro Forma Revenue was
  
  $88.1 million
  
• GAAP-reported revenue was
  
  $57.6 million
  
  , a 203% increase compared to the prior year
• Adjusted EBITDA was
  
  $5.9 million
  

Operational Highlights

• Opened second Illinois Mission Dispensary in
  
  Calumet City
  
  , and recently announced 2021 expansion plans in
  
  Illinois
  
  which includes the build out of an up to 558,000 square foot cultivation and production facility
• Completed expansion and retrofit of cultivation and production facility in
  
  Georgetown, MA
  
  and
  
  Elk Grove Village, IL.
  
  Continued construction on state-of-the-art 185,000 square foot production facility in
  
  Commerce, California
  
  , fully funded and on track for Q2 2021 opening
• Third
  
  Massachusetts
  
  dispensary in
  
  Brookline
  
  on track for Q2 2021 opening
• Completed sale leaseback transaction with Innovative Industrial Properties; ended year with
  
  $18.9 million
  
  of cash and
  
  $47.3 million
  
  in long-term debt due in
  
  May 2024
  

Management Commentary

“4Front’s strong fiscal 2020 performance is validation that our core strategy of replicating low-cost production methods, developed and refined within our

Washington

facilities, combined with our steadfast focus on execution is working,” said

Leo Gontmakher

, Chief Executive Officer of 4Front. “We ended 2020 with tremendous business momentum that we have carried into the new year, as we scaled and replicated our operations across the growing adult-use markets of

Massachusetts

,

Illinois

and

California

.”

Mr. Gontmakher added, “Our strong performance was driven by growing consumer demand for our quality manufactured products introduced in

Massachusetts

over the last year, the continued strength of the

Illinois

market, and a solid quarter out of our

Washington

facilities. We also completed the construction of our second

Illinois

dispensary in

Calumet City

, which opened in December, plus our cultivation/manufacturing facilities in

Illinois

and

Massachusetts

which we successfully transitioned into the ‘Washington Way’ with cultivation yields now meeting or exceeding those from our

Washington

facilities.”

Mr. Gontmakher concluded, “We are well positioned to further scale the business and execute on our expansion strategy in 2021. This includes significantly expanding our cultivation and manufacturing footprint in

Illinois

and entering the

$3 billion


California

market. Further bolstering our financial position is the fact that we are now generating positive operating cash flow, in line with our stated goals from the start of the year. Given the strength of our operations, I am pleased to reiterate our 2021 guidance of

$170

–

$180 million

in Pro Forma Systemwide Revenue and

$40

–

$50 million

in Adjusted EBITDA, with the longer-term view to generate

$650 million

in revenue and

$250 million

in EBITDA based on our current licensed footprint.”

Business Updates and Developments

Q4 2020 Systemwide Pro Forma Revenue increased 12% quarter-over-quarter to

$25.0 million


. This growth was driven by continued robust activity across the Company’s portfolio of operating assets, led by the first full quarter of recreational sales in

Massachusetts

and the opening of 4Front’s second

Illinois

retail location in Calumet City.

Q4 Adjusted EBITDA increased 59% quarter-over-quarter to

$5.9 million

representing adjusted EBITDA margin of 24%.

The Company continued to demonstrate considerable operating leverage in the fourth quarter, exceeding internal expectations, after initially achieving profitability during the third quarter of 2020.  Through the combination of 4Front’s low-cost production model, tight expense controls, and accelerating revenues the Company is well positioned to extend its profitability as it scales up its operating footprint. The Company achieved positive operating cash flow of

$3.2 million

in Q4 2020 and remains poised to show significant operating leverage in 2021.

In Q4 2020 4Front opened its second Illinois Mission Dispensary in

Calumet City

, and recently announced additional 2021 expansion plans in

Illinois

.

The expansion plan includes the build out of an up to 558,000 square foot cultivation and production facility (the “Facility”), which the Company recently secured financing to build. Subsequent to the year end, the Company entered into definitive agreements with both the landowner and an affiliate of Innovative Industrial Properties, Inc., to acquire the land for

$6.5 million

and fund the approximately

$45 million

buildout of phase one of the Facility. The first phase constitutes 258,000 square feet of building comprising 65,000 square feet of flowering canopy with approximately 70,000 square feet of manufacturing space and is expected to be operational in the fourth quarter of 2022.

The Company’s fully-funded, state-of-the-art 185,000 square foot manufacturing only facility in

Commerce, California

is nearing completion and is expected to be ready to serve the

California

cannabis market in Q2 2021.

The Company is planning to launch its first full line of edibles, tinctures and vape products on

California

retail shelves starting in

May 2021

.

Construction remains on schedule at the Company’s third

Massachusetts

dispensary in

Brookline

.

Final inspection by the Cannabis Control Commission anticipated to occur in

June 2021

and the Company remains confident that it will open the

Brookline

dispensary in Q2 2021.

2021 Outlook

Based on the continued strength of the Company’s operations and robust consumer demand, 4Front reiterates its previously announced FY 2021 guidance and anticipates Systemwide Pro Forma Revenue of

$170

-180 million and Adjusted EBITDA of

$40

-50 million. This guidance is fully funded and contemplates only current operations plus the opening of the

Brookline, Massachusetts

dispensary and the

Commerce

production facility in Q2 of 2021. If such openings are delayed due to Covid-19, guidance could be negatively affected.

(Please see Note Regarding Non-GAAP Measures, Reconciliation, and Discussion below.) (*Please see the Financial Statement section below, and the Company’s Fourth Quarter 2020 Condensed Consolidated Financial Statements and Management Discussion and Analysis (“MD&A”), available under the Company’s

EDGAR

profile)

Additional Details

As of the date of the MD&A, there were the equivalent of 566,186,697 Class A Subordinate Voting Shares outstanding when calculated as if all share classes were converted to Subordinate Voting Shares. For further details regarding 4Front’s share structure, please see its profile at


www.thecse.com


.

Conference Call

The Company will also host a conference call and webcast on

Tuesday, April 6, 2021

at

5:00 p.m. ET

to review its operational and financial results and provide an update on current business trends.

To join the call, dial 1-877-407-0792 toll free from

the United States

or

Canada

or 1-201-689-8263 if dialing from outside those countries. The webcast can be accessed at


this link


.

The call will be available for replay until

Tuesday April 13, 2021

. To access the telephone replay, dial 1-844-512-2921 toll free from

the United States

and

Canada

, or 1-412-317-6671 if dialing from outside those countries, and use this replay pin number: 13717894.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas,

Crystal Clear

, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.

Headquartered in

Phoenix, Arizona

, 4Front has operations in

Illinois

,

Massachusetts

,

California

,

Michigan

, and

Washington state

. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the entire cannabis value chain. For more information, visit 4Front’s website


www.4frontventures.com


.

Financial Statements

4FRONT VENTURES CORP.



Formerly 4Front Holdings, LLC



Consolidated Balance Sheets



As of

December 31, 2020

and

December 31, 2019

4FRONT VENTURES CORP.



Formerly 4Front Holdings, LLC



Consolidated Statements of Operations and Comprehensive Loss



For the Years Ended

December 31, 2020

and 2019

Note Regarding Non-GAAP Measures, Reconciliation, and Discussion

In this press release, 4Front refers to certain non-GAAP financial measures such as Systemwide Pro Forma Revenue and Adjusted EBITDA. These measures do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other issuers. 4Front defines Systemwide Pro Forma Revenue as total revenue plus revenue from entities with which the Company has a management contract, or effectively similar relationship (net of any management fee or effectively similar revenue) but does not consolidate the financial results of per US GAAP ASC 810. 4Front considers this measure to be an appropriate indicator of the growth and scope of the business.

Adjusted EBITDA is defined by the Company as earnings before interest, taxes, depreciation and amortization less share-based compensation expense and one-time charges related to acquisition, financing related costs and other non-recurring expenses. 4Front considers these measures to be an important indicator of the financial strength and performance of our business.

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in

the United States

.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, statements regarding when or if transactions will close or if/when required conditions to closing are attained, the impact of the transactions on the business of 4Front and other statements regarding future developments of the business. Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on satisfying closing conditions, [obtaining regulatory approvals]; and engagement in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

View original content to download multimedia:

http://www.prnewswire.com/news-releases/4front-announces-fourth-quarter-and-fiscal-year-2020-results-and-provides-business-update-301263476.html

SOURCE 4Front